New evidence that a statin can be a complementary therapy if you're receiving cancer treatment (immunotherapy in particular).

Statins neither cause nor cure cancer: meta-analyses of randomized trials show no effect
Reviews the evidence on statins and cancer. A 2012 meta-analysis of 134,537 participants in 22 RCTs found identical cancer incidence (1.4% per year) and mortality (0.5% per year) in statin users and non-users, and a 2023 meta-analysis of 35 RCTs found the same. Anticancer effects in specific contexts remain preclinical or suggestive.




